The nominal deal value is $236M, and the buyout price is a 40% premium to Friday’s close.
SLTM has a motley collection of medical devices for cosmetic applications, including the Thermage radio-frequency system for skin tightening (originally owned by THRM) and the Lipisonix “body contouring” system (originally owned by MRX).
*The preeminent biotech “roll-up” company.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.